Entrada Therapeutics, Inc. financial statements
Entrada Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 25.42M | 10-K |
| Net income | −USD 143.75M | 10-K |
| Cash and equivalents | USD 90.39M | 10-Q |
| Total debt | USD 50.93M | EODHD |
Entrada Therapeutics, Inc. financials on 6ix · Entrada Therapeutics, Inc. on 6ix